Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

PDL 1 immunohistochemistry laboratory validation

Date

07 Oct 2016

Session

Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Presenters

Mogens Vyberg

Authors

M. Vyberg

Author affiliations

Institute Of Pathology, Aalborg University Hospital, 9000 - Aalborg/DK

More

Resources

Reserved to ESMO members

Login Join ESMO

Watch the webcast View the presentation

Resources from the same session

07 Oct 2016

PDL 1 Immunohistochemistry clinical validation with the example of thoracic tumours

Presenter: Solange Peters

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

Introduction

Presenter: Peter Schirmacher

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast

07 Oct 2016

Conclusions and clinical perspectives

Presenter: Rolf A. Stahel

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Webcast

07 Oct 2016

Beyond immunohistochemistry

Presenter: Ian Cree

Session: Joint Symposium ESMO-ESP: How to select patients for immunotherapy: The role of pathology

Resources:

Presentation

Webcast